Stockscreener 앱 받기
7.01
1.41%
-0.10
전일 마감가:
$7.11
열려 있는:
$7.01
하루 거래량:
294.06K
Relative Volume:
0.46
시가총액:
$725.09M
수익:
-
순이익/손실:
$-112.39M
주가수익비율:
-3.9755
EPS:
-1.7633
순현금흐름:
$-91.64M
1주 성능:
-0.57%
1개월 성능:
-1.27%
6개월 성능:
+25.18%
1년 성능:
+1.74%
1일 변동 폭
$6.85
$7.09
1주일 범위
$6.82
$7.31
52주 변동 폭
$4.73
$9.535
Aura Biosciences Inc Stock (AURA) Company Profile
명칭
Aura Biosciences Inc
전화
(617)500-8864
주소
80 GUEST STREET, BOSTON
Compare AURA vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
7.01 | 740.60M | 0 | -112.39M | -91.64M | -1.7633 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-26 | 재개 | Evercore ISI | Outperform |
| 2025-05-28 | 재개 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | H.C. Wainwright | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2022-07-19 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Aura Biosciences Inc 주식(AURA)의 최신 뉴스
Aura Biosciences Inc (AURA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AURA|Aura Biosciences Inc|Price:7.155|Chg%:+0.105 - TradingKey
BlackRock (AURA holder) discloses 4.4% Aura Biosciences stake in amended filing - Stock Titan
Aura Biosciences Inc (AURA) Institutional Confidence - TradingKey
Aura Biosciences Inc (AURA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aura Biosciences Inc (AURA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aura Biosciences Inc (AURA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AURA|Aura Biosciences Inc|Price:7.050|Chg%:-0.150 - TradingKey
Aura Biosciences Inc (AURA) Cash Flow - TradingKey
Aura Biosciences Inc (AURA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aura Biosciences Inc (AURA) Income Statement - TradingKey
Aura Biosciences Inc (AURA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aura Biosciences, Inc. Revenue Breakdown – BOATS:AURA - TradingView
Aura Biosciences Reaffirmed at Buy with Unchanged $23 Target on Bel-sar’s Vision-Sparing Potential - TipRanks
The Technical Signals Behind (AURA) That Institutions Follow - Stock Traders Daily
Price to earnings forward of Aura Biosciences, Inc. – NASDAQ:AURA - TradingView
Price to book forward of Aura Biosciences, Inc. – NASDAQ:AURA - TradingView
Enterprise value to revenue forward of Aura Biosciences, Inc. – NASDAQ:AURA - TradingView
Enterprise value to EBITDA forward of Aura Biosciences, Inc. – NASDAQ:AURA - TradingView
Price to sales forward of Aura Biosciences, Inc. – NASDAQ:AURA - TradingView
Form 4 Aura Biosciences Inc For: 8 July By Investing.com - Investing.com Nigeria
Aura Biosciences (AURA) director receives RSU and 60,000 stock option grant - Stock Titan
Aura Biosciences (NASDAQ: AURA) files initial Form 3 for director Jeremy Bender - Stock Titan
Aura Biosciences Announces Appointment of Jer - Moomoo
Aura Biosciences strengthens board with new independent director - TipRanks
Aura Biosciences Appoints Jeremy Bender to Board as Bel-Sar Advances Toward Potential Regulatory Approval for Choroidal Melanoma 1 – Minichart - Minichart
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors - The Manila Times
Jeremy Bender joins Aura Biosciences (NASDAQ: AURA) board as independent director - Stock Titan
Aura Biosciences appoints Jeremy Bender to Boar... - Pluang
Aura Biosciences Insiders Made A Wise Decision By Selling US$939k Worth Of Stock - 富途牛牛
AURA Q1 2026 Earnings: Wider-than-Expected Loss as Stock Climbs on Pipeline ProgressSpecial Dividend Alert - dars.gov.et
More Money In The Bank For Aura Biosciences Insiders Who Divested US$939k - simplywall.st
Executive at Aura Biosciences (AURA) receives 14,858 RSUs - Stock Titan
Aura Biosciences, Inc. ($AURA) Former President, CEO and Director 2025 Pay Revealed - Quiver Quantitative
AURA | Aura Biosciences, Inc. Common Executive Compensation - Quiver Quantitative
Form DEF 14A AURA BIOSCIENCES For: 29 June By Investing.com - Investing.com Nigeria
Aura Biosciences (NASDAQ: AURA) sets vote on 500M share authorization and equity plan tweak - Stock Titan
Aura Biosciences Inc Actuals & Estimates (BOATS:AURA) - TradingView
Aura Biosciences Inc Actuals & Estimates (NASDAQ:AURA) - TradingView
AURA Forecast — Price Target — Prediction for 2027 - TradingView
Precision Trading with Aura Biosciences Inc. (AURA) Risk Zones - Stock Traders Daily
Aura Biosciences Inc (AURA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AURA News | AURA BIOSCIENCES INC (NASDAQ:AURA) - ChartMill
Aura Biosciences Inc (AURA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aura Biosciences (AURA) seeks charter increase to 500M shares; equity-plan tweak - Stock Titan
Top Aura Biosciences Executive Quietly Unloads Shares in Notable Insider Move - TipRanks
Aura Biosciences (AURA) files Form 144 to resell 37,500 RSU shares - Stock Titan
Tax-related Aura Biosciences (AURA) insider sale covers RSU withholding - Stock Titan
Aura Biosciences (AURA) director awarded 15,000 RSUs and 30,000 options - Stock Titan
Aura Biosciences (NASDAQ: AURA) director receives RSUs and 30,000 stock options - Stock Titan
Aura Biosciences (AURA) director receives RSUs and stock options - Stock Titan
Aura Biosciences Inc (AURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aura Biosciences Inc 주식 (AURA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gibney Anthony S | See Remarks |
Jun 16 '26 |
Sale |
6.42 |
12,824 |
82,330 |
265,354 |
| Matrix Capital Management Comp | 10% Owner |
May 07 '26 |
Sale |
5.64 |
6,922,870 |
39,044,987 |
0 |
2.44%
0.02%
자본화:
|
볼륨(24시간):